All this will be just talk - he will say that how the stock price is undervalued - people will ask questions and he will give all answers - the big news will be no BTD and it has got delayed
In reality, dosing 1st patient for gVHD USA big deal - any other co would have spiked by 10-20%. It is a series condition and if successful this has good potential.
People have started just ignoring what he says. We really need to remove NP and we can see co fortunes and our fortunes change. If Novartis can remove their CEO NP is not a big deal.